The Journal of Commercial Biotechnology

Editorial: The Biotechnology Entrepreneurship Boot Camp: From Lectern to Printing Press

Stephen M Sammut

This issue of the Journal of Commercial Biotechnology focuses on the proceedings of the Seventh Annual Biotechnology Entrepreneurship Boot Camp held in conjunction with the Biotechnology

New paradigms in drug R&D: A personal perspective

David C U'Prichard

The Author discusses the recent productivity problems in the pharmaceutical industry, in the context of his 30 year career, and the current responses of the industry driven strongly by disag

Project, Product or Company

Arthur Boni

This article focuses on the essentials of building effective, collaborative, team-based organizations. The entrepreneurs and innovators who found and build technology-based organizations

The Basics of Coverage, Coding, and Reimbursement

Robert Wanerman

The process of commercializing a new item or service in the U.S. health care market involves three distinct but necessary components: coverage, coding, and reimbursement.Â This article pr

Transition from the Lab to the Clinic

James G Kenimer

Before considering the specific regulatory requirements and expectations relating to your product it is informative to understand who regulates and why.

Building Teams in Entrepreneurial Companies

Arthur Boni

This article focuses on the essentials of building effective, collaborative, team-based organizations. The entrepreneurs and innovators who found and build technology-based organizations

The Pitch to Investors and Partners

Arthur Boni

This article covers the essentials of constructing and delivering a â€œpitchâ€ of a business opportunity to potential investors or corporate partners.Â We advocate constructin

Strategic Engagement of the Science-Business Media

Moira A. Gunn

As surely as the bio-enterprise can benefit from positive media coverage, it cannot thrive in the face of unanswered negative and/or inaccurate media attention. On all counts, the bio-ent

Achieving optimal financial and strategic transaction outcomes for small to mid-sized privately funded start-ups

Benjamin P Chen

Partnering With the NIH: Now Part of the â€œValue Propositionâ€ for Start-ups

Steve Ferguson

For many years the United States has led the world in government support for non-military research and development (R&D), especially support for work that directly relates to health a

Licensing, Partnering, Strategic Alliances and University Relationships

Wesley Daniel Blakeslee

The biopharmaceutical industry has been undergoing change for a number of years and that change is accelerating.Â Larger pharmaceutical companies are acquirin

What Every Biotech Entrepreneur Needs to Know about VC Due Diligence

Stephen M Sammut

Due diligence, as it applies to venture capital, is actually imprecise. Origins of the term are based in banking case law. Due diligence to the attorney is more of a precise concept. A be

Valuation Methods in Early-Stage Biotechnology Enterprises: The â€œVenture Capital Methodâ€ at Work

Stephen M. Sammut

Valuation approaches to biotechnology companies by angel investors and venture capitalists often appear to the entrepreneurs to be based on voodoo rather than sound principles of finance. Wh

The Art of the Cap Table

Ashley John Stevens

This article provides an overview of the impact of raising capital on the equity ownership structure of a biotechnology company. The equity ownership structure as captured in a table of capi